JACQUELINE ROSENBAUM: Open Payments
NPI 1710496757 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 24 payments from 10 companies in 2025. Trend: 2023 $235 · 2024 $348 · 2025 $688
Food & beverage: $615Education: $74
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 7 | $145 |
| Regeneron Healthcare Solutions, Inc. | 4 | $135 |
| Alexion Pharmaceuticals, Inc. | 1 | $123 |
| LEO Pharma Inc. | 3 | $89 |
| ABBVIE INC. | 3 | $60 |
| CSL Behring | 2 | $51 |
| UCB, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
Products named: OPZELURA, KOSELUGO, DUPIXENT, ADBRY, SKYRIZI, Hizentra, LIBTAYO, Bimzelx.
Industry payments across NY — which companies pay providers there.
